Skip to content

Clinical trials

Completed Observational Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Status: Completed Clear all

345 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20025
20038
20049
20056
20065
20079
200812
200921
201013
201118
201214
201318
201416
201515
201624
201714
201820
201926
202012
202119
202226
20238
20248
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed345

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris10
National Institute on Aging (NIA)9
National Institute of Mental Health (NIMH)8
NYU Langone Health6
National Institute of Neurological Disorders and Stroke (NINDS)5
University Hospital, Bordeaux5
Washington University School of Medicine5
Amoneta Diagnostics SAS4
Eisai Co., Ltd.4
Institut National de la Santé Et de la Recherche Médicale, France4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease345
Dementia104
Cognitive Dysfunction103
Dementia, Vascular21
Frontotemporal Dementia19
Parkinson Disease17
Lewy Body Disease16
Memory Disorders16
Disease13
Neurodegenerative Diseases13

Trials

Showing 1 to 25 of 345. Each trial links to its page on Pharma Observatory.

245 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.